Clinical Trials Logo
  1. Home
  2. Drug Dependence
  3. NCT01068847

Drug Discrimination in Methadone-Maintained Humans Study 3 — OMDD3  

Drug Dependence Clinical Trial

Official title:
Drug Discrimination in Methadone-Maintained Humans Study 3

Clinical Trial Summary

This study involves giving psychoactive drugs intramuscularly (injected into the muscle of the upper arm or the hip) and/or orally, and measuring the participant's ability to tell the difference between one drug and another, as well as measuring the effects of the drugs on mood, physiology (e.g., heart rate, blood pressure, respiration rate) and behavior. Each participant will receive 2-4 of the listed interventions.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01068847
Study type Interventional
Source University of Arkansas
Contact
Status Completed
Phase Phase 1
Start date February 2010
Completion date November 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT02564341 - Targeting Effective Analgesia in Clinics for HIV - Intervention N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT00593463 - Drug Discrimination in Methadone-Maintained Humans Study 1 Phase 1
Completed NCT03678051 - CBT4CBT for Women in Residential Treatment for Substance Use Disorders N/A
Recruiting NCT04003948 - Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification Phase 2
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT01449981 - Development and Testing of Adolescent Twelve-Step Facilitation N/A
Completed NCT00183118 - Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment) Phase 1/Phase 2
Completed NCT00047866 - Brain Function in Response to Motivational Stimuli N/A
Recruiting NCT03333460 - Transcranial Magnetic Stimulation for Cocaine Addiction N/A
Completed NCT02124980 - Automated Recovery Line for Medication Assisted Treatment N/A
Terminated NCT00975416 - Oxytocin and Cognitive Behavioral Therapy in Drug Dependence Phase 4
Completed NCT00265512 - LINK: Aftercare Monitoring Project N/A
Completed NCT00706901 - Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Withdrawn NCT00675532 - Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol). N/A
Active, not recruiting NCT03539575 - CB1R in Synthetic Psychoactive Cannabinoids N/A
Completed NCT01246401 - Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Phase 1/Phase 2
Completed NCT01096550 - Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans N/A